Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.


InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)


Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,

Blue Horseshoe Stocks: CAPR Recap & More

Capricor Therapeutics, Inc. CAPR

We included CAPR in yesterday’s premarket watchlist after noticing some abnormal volume and price action in the stock during the previous session. Prior to that it had been trading sideways for more than a month.

It turns out our alert came just in the nick of time, because yesterday CAPR exploded for its largest single-session spike in years. The stock opened at 1.50 and managed to run as high as 2.65, filling a good portion of the large gap on its chart, left in May. It came out to an intraday push of 77% which came on monstrous volume of just under 80 times the monthly average.


SPDR S&P500 ETF (SPY)

We discussed tracking the SPY Weekly $249.50 & $250 Calls as conditions appeared favorable to another bullish day for the market in general. The fund made a pretty solid move during the session, and that produced some decent opportunities in our designated contracts.

The $249.50′s traded from .55 to a high of .83 (+51%), while the $250′s did slightly better with a run from .29 to .49 (+69%) just before lunch hour.


Helios and Matheson Analytics, Inc. HMNY

We last tagged HMNY on August 15th, and after a solid run, the stock went under consolidation for a few weeks. However, the downturn ended at the end of last week and the move it’s made since has been pretty impressive.

HMNY saw a low of 2.42 on Thursday, and yesterday the stock achieved a new high of 6.40. That represents a four -session upswing of 164% while volume over the same period has been significantly increased.


HTG Molecular Diagnostics, Inc. HTGM

We’re interested to track HTGM today after the company announced the issuance of two method patents on its technology. We’re seeing a moderate gap-up in the premarket, but there still appears to be the good chance for a solid upside here. The stock does have a recent history containing a huge spike to more than $12.

We’ll place it on watch, and look for it to establish a string of sessions recording higher highs and higher lows moving forward.


Extended Watchlist:
WAC, DMPI, KPTI, SPI, ARWR, ALRT, PZRX, CEI

Blue Horseshoe Stocks: MRTX Recap & More

 Mirati Therapeutics, Inc. MRTX

After reporting positive cancer trial results on Friday, we talked about MRTX being poised for a big move and we weren’t incorrect.

The stock exploded out of the gate right from the outset, and traded in an impressive range from 9.15 to 12.40 early on in the day. That was good for a 35% intraday run- excellent for a $9+ stock. This is the third time in as many weeks we’ve called a stock that was approaching the ten dollar range and saw it gain more than a third in value in a single session.

Not only did MRTX trade up big on many times more thanits average volume, but it managed to maintain well over half of its daily advance, so we’ll be interested to continue monitoring its activity as we kick off a fresh trading week.


Iconic Brands, Inc. ICNB

We want to place ICNB on bottom-watch after taking a look at the recent history of the chart. This stock exhibits some really nice volatility and is coming down off of a significant spike.

When it finds support and rebounds, we could see a notable swing trade opportunity. The last such swing took the stock from the .003 range to .014.

The company recently announced its brand of Prosecco endorsed by former supermodel Christie Brinkley would be carried by Publix stores, so we’ll also be looking for further updates on that part of the story as well.


Pluristem Therapeutics, Inc. PSTI

We tagged PSTI for observation roughly a month ago, and have since seen a moderate move up on the chart, and will want to continue monitoring the situation.

The run the stock has made thus far is a marginal 27%, but things this morning have taken an interesting turn as the company announced the FDA granted fast track status to one of its treatments.


Extended Watchlist:
RAD, ADYN, NBRV, ARWR, PTIE, BIOA, MBOT, TRXC, COGT

Blue Horseshoe Stocks: Review of Friday’s Half-Session & More

Repros Therapeutics, Inc. RPRX

We’re looking at RPRX as a potential momentum-play this morning. After drastically falling off of a precipice at the end of last month, the stock spent several weeks stepping its way down to a new 52-week low. However, in the few sessions since that time RPRX has been making a nice rebound that warrants our putting this play on watch today.

As you can see on the included chart there are a number of bullish signals in effect. There’s also a good bit of real estate between the current PPS and the next area of resistance on the chart, thanks to the stock’s big decline in October. A return to levels prior to that point would mean gains approaching the 100%-mark from here, so we’ll reserve a space on our watchlist for RPRX.


Pleasant Kids, Inc. PLKD  – Options

Since our first mention of this stock back on October 13th, we’ve witnessed one heck of a run from PLKD, with very few setbacks along the way.

We’ve showed the epic move the stock has made using a trendline on the following chart, running from our observed low of .0581 all the way up to the new high registered on Friday. at .279. That’s a mammoth 380% swing, and with the way things have been going for PLKD of late, it would be a mistake for us to let it slip off of our radars at this point.


The Bon-Ton Stores, Inc. BONT

BONT has proved itself to be an immensely successful bottom-call for us over the past week. We re-introduced this past winner on Monday morning, upon which time we would witness the stock trading at a low of 1.25. It proceeded to record four consecutive sessions of higher highs and higher lows throughout last week, just as we’d hoped to see.

BONT’s fantastic recovery carried it to a new high of 2.83 on Friday, which represented an intraweek increase of 126%, congratulations to anyone who made a play on BONT during the short week!


HydroPhi Technologies, Inc. HPTG We’d also like to comment on HPTG, which made an appearance in Friday’s premarket report and ended the short week with a long intraday run from .0027 to .005. It worked out to a 85% spike, and despite being just a half-day, the stock made that move on heavier-than-average volume.


Extended Watchlist:
ARWR, AVXL, CEGX, FROT, LATX,

Blue Horseshoe Stocks: PZOO News & More

Pazoo, Inc. PZOO

We come back to touch base with PZOO this morning as the company has released an update on its marijuana testing facility in Las Vegas. It’s significant in that PZOO has secured a loan for the capital to put the finishing touches on the laboratory, the terms of which state that the full amount will be paid from the proceeds of the lab itself.

The company also made some lofty claims, namely that it has such an impressive roster of clients-in-waiting, that when the labs do open, they will be in a position to break even in the first month of operation! We’re being told that this cash infusion will have things on track for a November grand opening, so we’re going to begin to monitor PZOO more heavily in the weeks ahead as more updates are sure to be forthcoming.

We also want to point out the current setup on the PZOO chart on the annotated snapshot below:

WHIPPANY, N.J., Sept. 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC: PZOO) is pleased to report that Pazoo has received a $200,000 Loan to be paid back from the revenue and earnings of the Las Vegas Facility.  There can be no debt to equity conversion as this is a more conventional form of financing.

The Note holder was so impressed by the Las Vegas Lab, and more so by the amount of growers that have committed to exclusively test with Pazoo, Inc subsidiary MA & Associates, LLC, that he was comfortable to be paid back from the revenue and earnings that will be generated from the Lab.  In fact, based on the commitments from growers, Pazoo management is confident that the lab will be at least break even within the first 30 days of operation, and will quickly transition to profitability.

Pazoo expects to have the Colorado testing facility to officially be under the control of Harris Lee Colorado, LLC on or about October 14 and have the Las Vegas Facility operational and testing product in the latter part of the 4th quarter.

David Cunic, CEO, states, “The moment is finally upon us. This is going to be an watershed 4th quarter for Pazoo and hoping for an explosive 1st quarter of 2016. We are very excited for the ownership transition in Colorado.  We have several growers in Colorado that are just waiting for Harris Lee Colorado, LLC to take over so they can begin testing with Harris Lee Colorado, LLC. Everyone can just feel the momentum and it has energized the team to see what’s in front of us.”  >> Full PR

We also suggest that our readers check out the official webcast the company recently published which essentially addressed every facet of the business: >>>VIEW WEBCAST


Extended Watchlist:
ARWR, CNAT, EGYH, SGNL, BRWC